Top 50 Life Science VC Funds & Investors in Canada (September 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
FACIT
VC Fund
|
9 | Canada, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Medical Device | $1.5M–$35M |
|
StandUp Ventures
VC Fund
|
7 | Canada, United States | Seed, Series A, Pre-Seed | Software, SaaS, Artificial Intelligence | $317k–$14M |
|
Anges Quebec
VC Fund
|
6 | Canada, Spain, United States | Seed, Angel | Software, Health Care, Artificial Intelligence | $376k–$3.4M |
|
Real Ventures
VC Fund
|
6 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $700k–$50M |
|
Panache Ventures
VC Fund
|
6 | Canada, United States, Israel | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $713k–$20M |
|
Amplitude Venture Capital
VC Fund
|
6 | Canada, United States, Israel | Series B, Series A, Seed | Biotechnology, Health Care, Therapeutics | $3.2M–$142M |
|
Pallasite Ventures
VC Fund
|
5 | Canada, United States | Seed, Series A, Series B | Software, Health Care, Biotechnology | $750k–$115M |
|
Golden Ventures
VC Fund
|
5 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.5M–$49M |
|
BDC Venture Capital
VC Fund
|
5 | Canada, United States, Japan | Series A, Seed | Software, Information Technology, Artificial Intelligence | $600k–$20M |
|
Toronto Innovation Acceleration Partners
VC Fund
|
5 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Biotechnology, Software | $13k–$8M |
|
E-Fund
VC Fund
|
5 | Canada, China, United States | Seed, Pre-Seed | Health Care, Medical, Medical Device | $279k–$4.2M |
|
Fonds de solidarité FTQ
VC Fund
|
5 | Canada, United States, Israel | Venture - Series Unknown, Series A | Manufacturing, Biotechnology, Health Care | $500k–$50M |
|
Ontario Centre of Innovation
VC Fund
|
4 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Medical, Software | $7.3k–$3.2M |
|
Radical Ventures
VC Fund
|
4 | United States, Canada, United Kingdom | Seed, Series A, Series B | Artificial Intelligence, Software, Information Technology | $2M–$200M |
|
MaRS Investment Accelerator Fund
VC Fund
|
4 | Canada, United States | Seed, Pre-Seed, Series A | Software, Health Care, Analytics | $368k–$14M |
|
Apjohn ventures
VC Fund
|
4 | United States, Canada | Series A, Series C | Health Care, Biotechnology, Life Science | $2.5M–$39M |
|
Sustainable Development Technology Canada
VC Fund
|
3 | Canada, United States, Brazil | Grant, Seed, Pre-Seed | Manufacturing, Energy, Renewable Energy | $73k–$7.4M |
|
Ramen Ventures
VC Fund
|
3 | Canada, United States | Seed, Pre-Seed, Angel | Software, Biotechnology, Health Care | $120k–$3.2M |
|
Innovacorp
VC Fund
|
3 | Canada, Australia, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | $18k–$3.1M |
|
WUTIF
VC Fund
|
3 | Canada | Seed, Pre-Seed | Software, Health Care, Biotechnology | $100k–$3.8M |
|
BDC Capital’s Women in Technology Venture Fund
VC Fund
|
3 | Canada | Series A, Series B, Venture - Series Unknown | Software, Artificial Intelligence, SaaS | $2.6M–$200M |
|
Afore Capital
VC Fund
|
3 | United States, Canada, India | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Information Technology | $500k–$25M |
|
Inovia Capital
VC Fund
|
3 | Canada, United States, United Kingdom | Seed, Series A, Series B | Software, Artificial Intelligence, SaaS | $1M–$65M |
|
iGan Partners
VC Fund
|
3 | Canada, United States, Israel | Seed, Series A, Venture - Series Unknown | Health Care, Software, Medical | $500k–$17M |
|
GreenSky Ventures
VC Fund
|
3 | Canada, United States, United Kingdom | Seed, Venture - Series Unknown, Series A | Software, Information Technology, Artificial Intelligence | $709k–$12M |
|
MEDTEQ+
VC Fund
|
3 | Canada, United States | Seed, Series A, Venture - Series Unknown | Health Care, Medical Device, Biotechnology | $1.5M–$20M |
|
Lumira Ventures
VC Fund
|
3 | United States, Canada | Series A, Series B | Biotechnology, Health Care, Medical | $2.9M–$105M |
|
OrganiGram
VC Fund
|
3 | Canada, United States, Germany | Convertible Note, Series B, Debt Financing | Cannabis, Biotechnology, Medical | $1M–$12M |
|
Archangel Network of Funds
VC Fund
|
3 | Canada, United States | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Software, Medical Device | $10k–$19M |
|
Graphite Ventures
VC Fund
|
3 | Canada, United States | Seed, Series A, Pre-Seed | Software, Health Care, Artificial Intelligence | $729k–$31M |
|
Amplify Capital
VC Fund
|
2 | Canada, United States, India | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Education | $1.2M–$28M |
|
Theodorus III
VC Fund
|
2 | Belgium, Canada, France | Series A, Seed, Venture - Series Unknown | Health Care, Biotechnology, Software | $566k–$41M |
|
BoxOne Ventures
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Software | $281k–$115M |
|
Desjardins Venture Capital
VC Fund
|
2 | Canada, United States | Venture - Series Unknown, Seed | Software, Information Technology, Manufacturing | $620k–$228M |
|
Two Small Fish Ventures
VC Fund
|
2 | Canada, United States, Trinidad and Tobago | Seed, Series A | Software, Artificial Intelligence, E-Commerce | $2M–$25M |
|
Killick Capital
VC Fund
|
2 | Canada, United States | Seed, Pre-Seed | Software, Health Care, Aerospace | $213k–$10M |
|
OS Fund
VC Fund
|
2 | United States, Canada | Series A, Seed, Series B | Biotechnology, Health Care, Health Diagnostics | $1.6M–$53M |
|
Bee Partners
VC Fund
|
2 | United States, Canada, India | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, E-Commerce | $500k–$25M |
|
Builders VC
VC Fund
|
2 | United States, Canada, Mexico | Seed, Series A, Series B | Software, SaaS, Artificial Intelligence | $1.8M–$40M |
|
Coughdrop Capital
VC Fund
|
2 | United States, Canada | Seed, Pre-Seed | Software, Artificial Intelligence, FinTech | $125k–$9M |
|
Yaletown Partners
VC Fund
|
2 | Canada, United States, Belgium | Series A, Series B, Seed | Software, Enterprise Software, Information Technology | $603k–$60M |
|
Hazelview Ventures
VC Fund
|
2 | Canada, Slovakia (Slovak Republic) | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Big Data | $2M–$12M |
|
Charles River Laboratories International
VC Fund
|
2 | United States, Canada, France | Series A, Series B | Biotechnology, Health Care, Life Science | $12M–$103M |
|
Resolve Growth Partners
VC Fund
|
2 | United States, Canada | Series A, Venture - Series Unknown, Series B | Software, SaaS, Enterprise Software | $7M–$21M |
|
LVL1 Group
VC Fund
|
2 | Canada, United States, United Kingdom | Seed, Series A, Convertible Note | Software, Health Care, E-Commerce | $500k–$46M |
|
Groupe Roski
VC Fund
|
2 | Canada, United States | Seed, Series A | Health Care, Biotechnology, Medical | $1.5M–$20M |
|
Ontario Centres of Excellence
VC Fund
|
2 | Canada, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | |
|
Western Technology Investment
VC Fund
|
2 | United States, Canada, Nigeria | Seed, Series A, Series B | Software, Health Care, Information Technology | $1M–$100M |
|
Breakwater Ventures
VC Fund
|
2 | United States | Seed, Venture - Series Unknown | Financial Services, Credit, FinTech | $1.2M–$9M |
|
Accelerate Fund
VC Fund
|
2 | Canada, United States | Seed, Series A | Software, Health Care, Medical | $951k–$12M |
| Access all 363 VC funds in Canada Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 31
- Round size: Seed $1.5M–$8M; Series A $11M–$35M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Esphera SynBio — Creating modified exosomes that can be designed to have targeting moieties on their surface and a variety of protein or RNA payloads in their lumen.
- Hyivy Health — Hyivy Health is working on the first smart pelvic health rehabilitation system for patients and the clinicians who treat them.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
StandUp Ventures is a venture capital firm investing in female-founded companies in the B2B software and digital health sector.The firm is led by a team of experienced investors who have assembled a diverse advisory committee. The advisory committee is comprised of successful founders, venture investors, and other strategic mentors who willprovide high-touch support to the entrepreneurs. StandUp Ventures catalyzes strong deal flow across Canada from its network and syndicate seed rounds with Angels and US VCs.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 51
- Round size: Seed $1.3M–$5M; Pre-Seed $317k–$2M; Series A $2.3M–$14M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $16M in 2019
Portfolio highlights
- Wygo — This is why you've gotta go outside.
- GridBank — Enhance Your Social Media Engagement And Following With Stunning User-Generated Videos. Access A Wide Range Of Royalty-Free Stock Videos For Various Themes Including Travel, Productivity, Aesthetic Backgrounds, And More
- Pluvo — Financial forecasts calling for dry, complicated spreadsheets? Reclaim your time - no broken formulas, no duplication, no problems. Pluvo centralizes your data for dynamic scenario planning and unlimited forecasting!
Value-added investors for innovative entrepreneurs.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Angel
- Geography: Canada, Spain, United States
Investor stats
- Total investments: 174
- Round size: Seed $803k–$3.4M; Angel $376k–$1.3M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- SELL IT9 — Get top cash for your tech with SELLIT9, Canada's trusted trade-in service. Free same-day pickups, convenient drop-off locations, and pre-paid shipping labels nationwide. Fast, secure, and hassle-free!
- Solving.AI — Solving.AI is an AI training platform that helps in solving business software adoption issues.
- Elisa Interactive — Elisa Interactive operates an asset-light, prompt-to-environment software model designed to lower technical entry barriers in user-generated gaming ecosystems. Its core application platform, Me-Z-Scene, utilizes artificial intelligence to automatically arrange existing asset kits into complex 3D worlds based on natural language inputs. Thecompany's value proposition centers on empowering casual gamers and amateur builders to deploy custom virtual spaces without requiring coding or digital design expertise.
Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance,mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 276
- Round size: Seed $700k–$5M; Series A $3.1M–$24M; Series B $2.9M–$50M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $140M in 2017
Portfolio highlights
- DropGenie — DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of discovery through the generation of standardized and compatible scientific information.
- Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
- SPARK Microsystems — SPARK Microsystems delivers Low Energy Ultra-Wideband (LE-UWB) technology with ultra-low latency, high data throughput, and revolutionary power efficiency.
Canada's leading nationwide pre-seed venture fund.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 159
- Round size: Seed $912k–$6M; Pre-Seed $713k–$2.5M; Series A $6.3M–$20M
- Lead/follow: 14% lead, 86% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Proof — Make Government Decisions, Better.
- Ranger AI — Discover how Ranger RFX simplifies proposals with innovative tools designed for manufacturers. Improve accuracy, reduce downtime, and achieve cost savings today.
- Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
Amplitude Ventures is a full-stack venture capital firm focused on investing in precision medicine at the intersection of biology. and AI
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series B, Series A, Seed
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 37
- Round size: Seed $7M–$18M; Series A $3.2M–$85M; Series B $35M–$142M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $193M in 2024
Portfolio highlights
- Thryv Therapeutics — LQT Therapeutics is a biopharmaceutical company discovering and developing SGK1 inhibition therapies for Long QT Syndrome and various cardiovascular diseases and cancers.
- Mediar Therapeutics — Mediar Therapeutics is a preclinical stage biotechnology company developing antibody-based therapeutics to halt fibrosis in a variety of organ systems, including lung, liver, kidney, and skin.
- Congruence Therapeutics — ABOUT US We are a drug discovery company that is uniquely harnessing the power of protein dynamics, biophysics, machine learning and computational chemistry. Our Science Traditional drug design is limited At Congruence,
Pallasite Ventures is an agile venture capital firm providing early-stage financing for high-growth companies across a variety of industries.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 38
- Round size: Seed $750k–$5M; Series A $3.2M–$20M; Series B $14M–$115M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Ionomr — Ionomr designs & manufactures advanced ion-exchange polymers & membranes that enable high performance and efficiency in applications like water & wastewater treatment, hydrogen production and advanced energy storage.
- Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
- Aspect Biosystems — Pioneering the development of bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases.
Golden Ventures is a leading seed-stage venture capital fund, based in Toronto and investing across North America. We back bold teams and their transformative ideas.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 196
- Round size: Seed $1.5M–$7.5M; Series A $6.8M–$32M; Series B $14M–$49M
- Lead/follow: 19% lead, 81% follow
- Last fund: Likely still investing — raised $103M in 2024
Portfolio highlights
- Space — Space is a cloud filesystem that appears in Finder as a regular drive. Open and save files with the apps that are used in regular basis while Space keeps them in the cloud and up to date across the Macs. So that one can work with terabytes of files without filling the computer or carrying external drives.
- Terminal — Easily add 30+ telematics integrations to your application with a single API. Connect your application to the services you need, without worrying about the underlying details
- Powered by People — Powered by People is a values-driven wholesale platform featuring handmade, ethical products from makers in over 40 countries. Sign up now for pre-approved credit and net 60 terms at poweredbypeople.com
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets. The company helps create and develop strongCanadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises.BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Canada, United States, Japan
Investor stats
- Total investments: 527
- Round size: Seed $600k–$4.9M; Series A $2.7M–$20M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $500M in 2022
Portfolio highlights
- Spark — Spark provides the platform required to sell, market, close and report on your entire portfolio of new development projects.
- WhatsNexx — Sujintoto adalah situs slot online yang memberikan pelayanan deposit yang sat set dan withdraw cepet selama 24 jam
- Neurio Technology — Neurio makes ordinary appliances smart and homes more efficient by letting you know what’s going on, when you need to know it - like if you forgot to turn off your stove, when your kids are home from school, and if they’re watching TV when they should be doing homework. With a Neurio sensor, our smartphone apps let you know what’s happening inyour home, which appliances are in use and the amount of energy they use without having to install sensors at every device.
MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organizationthrough the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 87
- Round size: Seed $73k–$8M; Grant $13k–$100k; Pre-Seed $22k–$525k
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
- Grey Matter Neurosciences — Empowering seniors to restore brain function through the unique power of focused ultrasound.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities.The E-Fund involvesspecific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Canada, China, United States
Investor stats
- Total investments: 62
- Round size: Seed $474k–$4.2M; Pre-Seed $279k–$1M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Qase — Qase helps law firms and legal referral organizations streamline referrals, automate intake and booking, and collect forwarding fees online.
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
Fonds de solidarité FTQ is a private equity and venture capital firm specializing in investments in start-ups, early venture, mergers, business acquisitions, management buyouts, market development project or a buyout, financing for new programs, organic growth and cash flow, growth and expansion financings, development capital, business succession,financial restructuring, business transition financing, family and non-family buyout, consolidations, turnaround, and leveraged management buyouts. It also invests in new markets, product and business line developments, market diversification, interim financings, new product marketing, additional working capital, purchase of tangible and intangible assets, equipment modernization, equipment purchases or upgrades, and integrator projects. The firm has regional funds that do not invest in retail, real estate, farming, biotechnology, and financial services. Fonds de solidarité FTQ invests in small and medium-sized businesses. It typically invests in export projects, forest products, productivity improvement, natural resources, aerospace, agri-food, wood, pulp and paper, chemicals, construction and construction materials, printing, transportation equipment and automobiles, transportation services, furniture and fixtures, combinatorial chemistry and other lead generating technologies, mining and exploration, social economy, textiles, plastics, life sciences, business services, telecommunications, distribution and consumer goods, environment, equipment and machinery, financial services, information and communication technology, metal products, recreational tourism, and culture sectors. Within the culture sector, Fonds de solidarité FTQ seeks to invest in pre-production and creative projects, production projects, infrastructures and services, post-production projects, distribution, and broadcasting and multiplatform broadcasting. Within the environment sector, it invests in waste management and energy conversion for residual waste; air treatment and reduction of greenhouse gas emissions; processes to reduce industrial energy and water consumption; water treatment; and soil rehabilitation and decontamination (metals and organic compounds). Within the life sciences sector, Fonds de solidarité FTQ focuses on services for the biopharmaceutical industry; nutraceuticals and cosmeceuticals; diagnostics and medical supplies and equipment; biopharmaceuticals and generic drugs; biotechnology, and animal health. Within the tourism sector, it focuses on urban tourism, nature tourism, resort type tourism, and local tourism for Quebecers, and in the textiles sector it invests in companies engaged in development and production of specialty textiles as well as development of industrial applications for the construction, transportation, health and safety, and work apparel industries. Fonds de solidarité FTQ prefers to invest in Quebec and in companies impacting the Québec economy. It focuses on investing in the following regions- Abitibi –Témiscamingue, Bas Saint Laurent, Chaudière-Appalaches, Côte-Nord, Estrie, Gaspésie Îles-de-la-Madeleine, Lanaudière, Laurentides, Laval, Mauricie - Centre-du-Québec, Montérégie, Nord-du-Québec, Outaouais, and Saguenay-Lac-St-Jean. Fonds de solidarité FTQ seeks to invest in projects of $3 million or more and also provides loans of up to $ 2 million. It invests in companies in business succession sector having minimum capitalization of $500,000 and EBITDA of over $35.5 million in case of majority interest; equipment and machinery sector with average investment in excess of $3 million; environment sector with funding needs of more than $500000; financial services sector having net assets between $20 million and $50 million in equity; metal products sector having annual sales of over $5 million and financing needs of at least $2 million; and printing sector having investment needs of over $1 million. In the information technology sector, Fonds de solidarité FTQ seeks to invest $2 million as initial investments while total investments can be more than $10 million. It invests in the form of equity financing (common or preferred shares) and unsecured debt requiring no collateral (debenture). Fonds de solidarité FTQ can take both a minority interest including an equity stake of up to 49 percent as well a majority interest in its portfolio companies in case of business succession financing. It seeks a minority stake for the portfolio companies in the equipment and machinery sector. It typically holds its investments for a period of five to ten years in case of equity financing and for more than ten years in case of business succession financing. Fonds de solidarité FTQ began operation on June 23, 1983. It has its headquarters in Montreal in Canada with additional offices in the same city and Quebec in the same country.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Health Care
- Stage:Venture - Series Unknown, Series A
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 267
- Round size: Series A $6M–$50M; Venture - Series Unknown $500k–$40M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- Metal 7 —
- Namakor Holdings — We combine strategic investment and in-house operational expertise to untap the true potential of your industrial manufacturing businessNamakor Holdings is a private equity firm investing in mid-market manufacturing companies, driving growth, innovation, and global expansion.
- Premier Tech — Premier Tech has been focusing on skills development and recognition to constantly innovate, improve its operational excellence and deploy products and services that create value for its customers.
Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario
Show more...Investment focus
- Industry: Health Care, Medical, Software
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 52
- Round size: Seed $366k–$3.2M; Grant $7.3k–$110k; Pre-Seed $151k–$2.5M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Synakis — Own synakis.com today. Secure checkout and guided transfer support. No hidden fees.
- Script Runner — Script Runner provides AI-powered prescription delivery and logistics software for pharmacies and healthcare providers. The platform enables pharmacies and hospitals to manage last-mile prescription delivery using in-house drivers, Script Runner’s driver network, or integrated services such as Uber Direct. It supports route planning, ordertracking, and drone-based recurring deliveries for medications within defined distances. The software includes tools for secure payment collection at the door or online, along with data security and storage aligned with industry compliance standards. Script Runner also offers virtual care and virtual prescribing capabilities for minor ailments bundled with delivery, helping providers coordinate clinical services with logistics in a single system.
- Kare Chemical Technologies — Kare specializes in the research, development, and commercialization of catalysts, precursors, and industrial processes to produce pure cannabinoids (for example, CBD, THC, CBN, and rare cannabinoids) that are chemically identical to plant‑derived versions but made via synthetic routes.
Radical Ventures is an early-stage venture capital firm investing in entrepreneurs applying deep technology to transform massive industries.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 135
- Round size: Seed $2M–$27M; Series A $7M–$83M; Series B $30M–$200M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely actively investing — fresh fund, raised $250M in 2026
Portfolio highlights
- Emerald AI — Intelligence to transform energy-intensive AI data centers into AI-powered grid allies
- Muon Space — Earth intelligence for a Safe and Resilient World.
- Generalist AI — At Generalist, we are on a mission to build general intelligence for the physical world.
Working with Ontario talent to develop World Class Companies Learn More
Show more...Investment focus
- Industry: Software, Health Care, Analytics
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 164
- Round size: Seed $375k–$4M; Pre-Seed $368k–$1.5M; Series A $2.3M–$14M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $8.5M in 2014
Portfolio highlights
- Azoma — Ecomtent enables brands to create eCommerce content with Generative AI. Using Ecomtent's self-service tools, customers can generate their entire optimized Amazon listing, using our AI product photo generator, AI Generate infographics at scale, a+ content, and generate optimised copy.
- SELL IT9 — Get top cash for your tech with SELLIT9, Canada's trusted trade-in service. Free same-day pickups, convenient drop-off locations, and pre-paid shipping labels nationwide. Fast, secure, and hassle-free!
- TimeSmart.AI — A healthcare-focused solution for contract management, clinician timesheet review and approvals, payment tracking & contract compliance enforcement
Apjohn Ventures Fund is a new venture capital firm based in Kalamazoo, Michigan established to invest primarily in early stage life sciences companies across the Midwest. The goal of the Fund is to provide investors with superior financial returns by making equity investments in innovative life sciences companies with sustainable and outstandinggrowth potential.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Life Science
- Stage:Series A, Series C
- Geography: United States, Canada
Investor stats
- Total investments: 15
- Round size: Series A $2.5M–$39M; Series C $3M–$34M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Tetra Discovery — Tetra Discovery Partners provides consulting services in drug discovery and development. They partner with Universities to commercialize intellectual property and conduct proprietary research on diseases affecting the central nervous system.Their research focuses on developing new treatments for depression and schizophrenia. Severe forms ofdepression affect 2–5% of the US population, while mood disorders impact 7% of the world’s population and rank among the top ten causes of disability.
- Tetra Therapeutics — Tetra Therapeutics is a clinical stage biotechnology company developing a portfolio of therapeutic products that will bring clarity of thought to people suffering from Fragile X syndrome, Alzheimer's disease, traumatic brain injury, and other brain disorders.
- Sierra Oncology — Sierra Oncology is late-stage clinical drug development biopharmaceutical company on a mission to deliver targeted therapies that treat rare forms of cancer.
At Sustainable Development Technology Canada (SDTC), they fund Canadian cleantech projects and coach the companies that lead them as they move their ground-breaking technologies to market.SDTC’s support of cleantech translates into jobs, growth, and export opportunities for Canadian companies, as well as economic, environmental and healthbenefits for all Canadians. They are independent but don’t work alone. A big part of their role is building and sustaining networks of partners and stakeholders from private industry, academia and governments, at home and abroad. They operate at arm’s length and receive funding from the Government of Canada.
Show more...Investment focus
- Industry: Manufacturing, Energy, Renewable Energy
- Stage:Grant, Seed, Pre-Seed
- Geography: Canada, United States, Brazil
Investor stats
- Total investments: 265
- Round size: Seed $73k–$2.5M; Grant $772k–$7.4M; Pre-Seed $149k–$1.6M
- Lead/follow: 77% lead, 23% follow
Portfolio highlights
- Niricson — Niricson develops an AI-based predictive analytics SaaS platform for infrastructure asset management. Its AUTOSPEX platform and DRONIC provide asset managers and civil engineers critical insights and multi-defect layer visualization for the current condition of their assets.
- Solaires Entreprises Inc — Solaires Entreprises Inc is a Canadian cleantech company located in Victoria, BC, that consists of a team of 23 scientists, engineers, and business professionals. Solaires is focused on developing the next generation of solar cells by replacing silicon with perovskite through an innovative and sustainable manufacturing process resulting inaffordable solar photovoltaics with higher energy conversion efficiency.
- Progressive Planet Solutions — Progressive Planet Solutions Inc is a metal/mineral based company that deals with the exploration & development of zeolite minerals.
We angel invest in founders who will improve the lives of millions. Based in Toronto, Canada.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Seed, Pre-Seed, Angel
- Geography: Canada, United States
Investor stats
- Total investments: 24
- Round size: Seed $600k–$3.2M; Angel $500k–$600k; Pre-Seed $120k–$1.5M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- ALT TEX — ALT TEX is creating sustainable textiles regenerated from post-industrial waste.
- Spare — Spare is your all-in-one mobility operations platform, designed to provide an end-to-end platform ecosystem for operating modern paratransit and microtransit systems.
- Mayday — Time is your most valuable asset. Make sure you're spending it wisely.
Innovacorp is an early-stage venture capital firm that helps knowledge-based startups commercialize their technologies in the global marketplace. It invests in early stage Nova Scotia entrepreneurs, combining venture capital with business mentoring and incubation facilities. Innovacorp was established in 1995 and based in Halifax, Canada.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, Australia, United States
Investor stats
- Total investments: 155
- Round size: Seed $50k–$3.1M; Grant $25k–$91k; Pre-Seed $18k–$878k
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Bright Breaks — Bright offer on-site and virtual amenities for companies and employees. whether your team is on-site, working from home, or in between.
- Planetary — Planetary restores the chemistry of seawater so it can do what it has always done: support life and protect the planet.
- CarbonCure Technologies — CarbonCure Technologies creates, develops, and licenses solutions that consume waste CO2 to make better concrete. It spurs the market shift towards affordable green concrete, by enabling concrete manufacturers to convert waste CO2 into solid minerals, locked away as a solid within concrete during manufacturing. It is a green building technologycompany currently serving concrete product manufacturers in the US and Canada. It offers concrete producers the ability to manufacture green concrete products without compromising on either quality or price.CarbonCure is a retrofit innovation that repurposes CO2 gas from large final emitters as a feedstock in concrete plants. The gas is permanently converted into embedded solid mineral carbonates that yield material, environmental, and production advantages. By enabling concrete manufacturers to consume CO2 into concrete products during manufacturing, the technology differentiates an otherwise traditional commodity concrete product, while achieving superior material performance characteristics. In addition to technology, CarbonCure provides demand-pull marketing and environmental reporting/certification services to reinforce its customers’ exclusive competitive positioning. The technology is licensed at a very low-CAPEX to concrete producers, generating a recurring revenue stream.CarbonCure Technologies was founded in 2007 and is headquartered in Halifax, Nova Scotia.
WUTIF Capital (VCC) Inc. is a novel angel fund that co-invests with angel investors in promising new technology ventures in British Columbia. WUTIF was formed in mid-2003 and made its first investments in late 2004.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: Canada
Investor stats
- Total investments: 77
- Round size: Seed $100k–$3.8M; Pre-Seed $279k–$1.5M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- Carbonyx — Carbonyx transforms waste into carbon-negative advanced materials for industry.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BDC Capital Women in Technology (WIT) Fund is one of the world’s largest venture capital funds
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: Canada
Investor stats
- Total investments: 35
- Round size: Series A $2.9M–$83M; Series B $13M–$200M; Venture - Series Unknown $2.6M–$42M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Waabi — Waabi operates as a self-driving technology start-up. Waabi is bringing the promise of self-driving closer to commercialization than ever before.
- Swift Medical — Get advanced wound care powered by AI with Swift. 32M+ calibrated images enable 35% faster healing, 79% faster assessments, and 15% fewer hospitalizations.
- Eigen Innovations — Eigen combines imaging and AI to detect issues traditional vision systems miss, revolutionizing quality inspection.
Afore Capital backs product-centric founders at the pre-seed stage exclusively. The investment team brings 16 years of founding product experience (Android and Twitter) and 7 years of institutional investing experience (Founder Collective and Foundation Capital). Their sweet spot is the ~$1M pre-seed round, where they can lead the round as aninstitutional investor alongside high value angels.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Canada, India
Investor stats
- Total investments: 267
- Round size: Seed $2.1M–$10M; Pre-Seed $500k–$3M; Series A $7M–$25M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $185M in 2025
Portfolio highlights
- CivilGrid — CivilGrid centralizes utility, environmental, geotechnical, and other site data in a SaaS platform where your teams can collaboratively scope and plan projects.
- Hypercubic — Hypercubic is agentic AI for mainframe modernization, helping enterprises and governments preserve institutional knowledge and modernize COBOL.
- Tideshiftai — TideShiftAI leverages AI to provide personalized insights and forecasts for businesses, helping them optimize operations and enhance decision-making.
We support entrepreneurs at every stage of their journey and build technology companies that generate a positive impact on society.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 410
- Round size: Seed $1M–$8.3M; Series A $2.3M–$20M; Series B $5M–$65M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $300M in 2024
Portfolio highlights
- Modem — Your dev team's auto-triage Product Manager
- Cohere — Cohere builds powerful models and AI solutions enabling enterprises to automate processes, empower employees, and turn fragmented data into actionable insights.
- TripleLift — Turn fragmented media into a coordinated system. TripleLift connects data, creative, and supply to drive measurable advertising outcomes.
iGan Partners is one of Canada's largest healthcare-focused venture capital firms, investing across North America. We provide capital and expertise to scale innovative healthcare solutions.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 50
- Round size: Seed $500k–$5.2M; Series A $3.9M–$17M; Venture - Series Unknown $10M–$14M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $250M in 2022
Portfolio highlights
- Docsi — DOCSI provides preference card optimization, surgeon engagement and supply chain cost reduction through novel digital solutions.
- Exact Imaging — Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution. The system enables visualization and targeting of suspicious regions, in addition to performing systematic TRUS biopsies for prostate cancer imaging.
- Adenocyte — Adenocyte. Early detection and prevention of pancreatic cancer.
GreenSky Ventures is a Toronto-based firm that makes investments in early-stage Canadian technology companies.GreenSky Ventures seeks early-stage B2B technology companies in Canada, emphasizing protectable IP and experienced management. It makes investments in early-stage technology companies through its affiliated venture capital funds, GreenSkyAccelerator Fund I, II and III. Their principals bring a unique combination of experience in technology, law, and finance to high-growth potential companies and dedicated entrepreneurs.GreenSky Capital was founded in Toronto, Ontario in 2010 by Geoff Simonett and Michael T. R. List.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $766k–$3.3M; Series A $1.1M–$4.5M; Venture - Series Unknown $709k–$12M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $117k in 2024
Portfolio highlights
- Derapi — Derapi is a universal API for distributed energy resource (DER) devices, including solar, battery storage, EV chargers, smart thermostats, heat pumps, and other behind-the-meter loads. Derapi unlocks the full value of DERs by removing bottlenecks related to data integration, reducing data infrastructure costs and speeding time to market for DERsoftware developers, DER device manufacturers, and others in the DER ecosystem.
- GridBank — Enhance Your Social Media Engagement And Following With Stunning User-Generated Videos. Access A Wide Range Of Royalty-Free Stock Videos For Various Themes Including Travel, Productivity, Aesthetic Backgrounds, And More
- Trolley — Trolley is the best payouts platform for businesses needing to pay creators, musicians, artists, freelancers, or on-demand workers.
MEDTEQ+ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them andtheir partners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 36
- Round size: Seed $1.5M–$4M; Series A $3M–$20M
- Lead/follow: 53% lead, 47% follow
- Last fund: May invest from a new fund soon — raised $11M in 2018
Portfolio highlights
- AI4Eyes — AI4Eyes offers an end-to-end AI software & data collection platform for fast, precise, and consistent ocular diagnostics, enabling clinicians to detect and improve eye health.
- NURA Medical — Discover NurEx's medication safety software and its novel weight estimation technology, designed for healthcare professionals. Experience easy-to-use pediatric dosing, accurate weight measurement, and streamlined formulary management to enhance patient safety and reduce medication errors. Book a demo today.
- Swiftsure Innovations — Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes.It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.Creative Destruction Labssupports the company.
Lumira Ventures, a later stage VC, partners & invests in best-in-class innovative biotherapeutic & medtech entrepreneurs building transformative companies.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 122
- Round size: Series A $2.9M–$105M; Series B $12M–$75M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Nervonik — Explore Nervonik neuromodulation devices that are working to redefine peripheral nerve stimulation with advanced technology for high motion.
- Contraline — Contraline is a medical device company that has developed a proprietary injectable hydrogel platform for use in reproductive and contraceptive applications. Contraline's first product, Adam, is implanted into the vas deferens through a minimally invasive, outpatient procedure and once implanted, the gel effectively blocks sperm. Adam isnon-hormonal, designed to last years, and easily reversible.
- Cour Pharmaceuticals Development — Reprogramming the immune system. Restoring lives.At COUR, we are developing targeted therapies that re-establish calm within the immune system and help rest ...
OrganiGram is a producer and distributor of medical and recreational cannabis. They are dedicated to consistently providing clients with the highest grade medicine and service. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international businesspartnerships to extend the Company’s global footprint.
Show more...Investment focus
- Industry: Cannabis, Biotechnology, Medical
- Stage:Convertible Note, Series B, Debt Financing
- Geography: Canada, United States, Germany
Investor stats
- Total investments: 12
- Round size: Convertible Note $1M–$12M
- Lead/follow: 92% lead, 8% follow
Portfolio highlights
- Sanity Group — Sanity Group is a holistic European Cannabis company focusing on health, wellbeing, and scientific research. To utilize the full potential of its health benefits, Sanity Group is investing in fundamental research of the cannabis plant and its active ingredients as well as in specific areas of application.It was founded in 2018 and headquarteredin Berlin, Germany.
- Phylos — Revolutionary cannabis seed varieties with outstanding traits that have been bred to grow uniformly like clones.
- Open Book Extracts — Premium wholesale cannabinoid supplier offering CBD, CBN, CBG, CBC, and THCV isolates. Water-soluble formulations for beverages. Custom formulation services. GMP-certified, research-backed cannabinoids.
Archangel is the overarching early stage investment fund based in Waterloo Region, the North Silicon Valley of North America.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 69
- Round size: Seed $10k–$3.8M; Pre-Seed $700k–$1.6M; Venture - Series Unknown $1.6M–$19M
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — raised $10M in 2021
Portfolio highlights
- myStoria — Backed by fertility doctors. Built by patients, for patients. Track symptoms, manage diagnoses, get advice, and start moving forward.
- Streamforge — Streamforge helps companies find the most relevant creators for their games and products using the most sophisticated platform and technology on the market.
- TimeSmart.AI — A healthcare-focused solution for contract management, clinician timesheet review and approvals, payment tracking & contract compliance enforcement
We've helped 175 founders build enduring companies - and we're ready to take it to the next level.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 35
- Round size: Seed $1.1M–$4.7M; Pre-Seed $729k–$6M; Series A $7.3M–$31M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $92M in 2023
Portfolio highlights
- myStoria — Backed by fertility doctors. Built by patients, for patients. Track symptoms, manage diagnoses, get advice, and start moving forward.
- InsideDesk — Reduce AR days, boost collections, and streamline billing operations with InsideDesk's centralized revenue cycle management platform.
- TimeSmart.AI — A healthcare-focused solution for contract management, clinician timesheet review and approvals, payment tracking & contract compliance enforcement
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Invest in transformational technologies that can achieve large scale solutions globally.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Education
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States, India
Investor stats
- Total investments: 44
- Round size: Seed $1.2M–$5M; Pre-Seed $1.2M–$2.5M; Series A $7.3M–$28M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $22M in 2020
Portfolio highlights
- Fex Energy — FeX Energy is a pre-commercial startup focused on developing renewable energy storage solutions.
- ThinkLabs AI — ThinkLabs AI is a specialist AI development and deployment firm. Its mission is to empower critical industries and infrastructure with trustworthy AI towards global energy sustainability.
- Carbon Upcycling — Our cities, roads, energy, AI, and all critical infrastructure are built on a foundation of concrete. And cement is the glue that holds it all together. Securing our tomorrow means securing our critical cement materials. It means building manufacturing independence, localizing supply chains, and investing...
Theodorus is the spin-off fund of Université Libre de Bruxelles that invests ininvest in early stage projects based on proprietary disruptive technologies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: Belgium, Canada, France
Investor stats
- Total investments: 21
- Round size: Seed $566k–$18M; Series A $1.3M–$41M; Venture - Series Unknown $3.6M–$20M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Icentia — Icentia provides a range of innovative medical tests for healthcare institutions. They are able to offer valuable solutions for major problems in the field of medical testing.
- Simmunome AI — We use AI to create accurate, comprehensive disease models using multi-omic data to determine the probability of success of a drug. Our clinical trial simulations allow you to gain insights, make go/no-go decisions, and de-risk your pipeline, getting you to market faster and reducing your R&D co
- Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 69
- Round size: Seed $1.3M–$9.5M; Pre-Seed $281k–$2M; Series A $744k–$115M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
- Opalia — Opalia is introducing a new era of dairy: functional, delicious, and sustainable dairy made from mammary cells.
- Thred — Thred is the first B2B Intent platform designed for AI. Act on accounts researching in ChatGPT, Gemini, and Claude.
Desjardins Capital makes it easy to grow your business with financial and strategic support. Investment capital and venture capital can help you meet your business goals.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Seed
- Geography: Canada, United States
Investor stats
- Total investments: 153
- Round size: Seed $1M–$5.2M; Venture - Series Unknown $620k–$228M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $120M in 2018
Portfolio highlights
- Vention — Design and order custom industrial equipment in days. Fast and easy-to-use cloud CAD, loaded with modular parts, that ship next day.
- Inscora — Inscora is the cyber-insurability platform for MSPs and MSSPs. Assess risk, accurately measure client insurability, and unlock new revenue - without adding operational burden.
- Vosker — Vosker provides remote area monitoring tech enabling you to take things further
Add a description for facebook
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A
- Geography: Canada, United States, Trinidad and Tobago
Investor stats
- Total investments: 47
- Round size: Seed $2M–$12M; Series A $5.2M–$25M
- Lead/follow: 13% lead, 87% follow
- Last fund: Likely still investing — raised $30M in 2024
Portfolio highlights
- Haply — Haply is a robotics company that provides haptic devices, prototyping, firmware, and virtual learning assistance.
- YScope — YScope is a software development company that provides log management and troubleshooting tools for automated failure prediction.
- Qubic Technologies — Qubic Technologies is a manufacturer of quantum microwave transmitters and receivers for remote sensing and communication.
Killick Capital is a leading Atlantic Canadian private equity firm, dedicated to partnering with Atlantic Canadian businesses and Aerospace businesses. Our team of professionals work closely with portfolio companies to maximize success.
Show more...Investment focus
- Industry: Software, Health Care, Aerospace
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 54
- Round size: Seed $525k–$10M; Pre-Seed $213k–$1.3M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- CoLab Software — The only tool purpose-built to simplify design reviews for engineering teams building complex products.
- Avalon Holographics — Avalon Holographics is designing next-generation holographic displays for commercial and consumer applications. The company is leading the next wave of display technology with light field displays that revolutionize the way people produce, view, and understand visual content. By replicating the experience of looking at real objects, Avalon’sdisplays produce realistic, comfortable, and accessory-free experiences.
- Sparrow BioAcoustics — Sparrow BioAcoustics ,developers of a smartphone stethoscope designed to gather and collaborate on medical-grade cardiac and pulmonary data.
We partner with future literate entrepreneurs who understand our unique time and place in history, with the ambition to author a better future for humanity.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Health Diagnostics
- Stage:Series A, Seed, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 49
- Round size: Seed $1.6M–$6M; Series A $5M–$32M; Series B $12M–$53M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Arzeda — Arzeda develops innovative products powered by its Intelligent Protein Design Technology, using generative AI-driven design to create, validate, and manufacture new proteins and enzymes that enhance our lives and protect our planet. Arzeda commercializes with Fortune 500 go-to-market partners across multiple industries, enabling higher-performing,more cost-effective solutions that are healthier and sustainable.
- A-Alpha Bio — Measure more protein interactions
- Kenota Health — Kenota Health develops next-generation rapid point-of-care system intended to be used for allergy testing in humans. Kenota's diagnostic tools are safe, simple, and offer a cheaper alternative to allergy testing using a thorough non-invasive technology, enabling physicians to improve patient outcomes.
Bee Partners, a preSeed venture capital fund, partners with Founders with the smarts, grit, and humanity to create tomorrow's machines. We invest in three vectors: Human Machine Interaction, Machine-to-Machine Learning, and Biological Machines.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, E-Commerce
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, India
Investor stats
- Total investments: 137
- Round size: Seed $1.2M–$5.5M; Pre-Seed $500k–$3.1M; Series A $4.6M–$25M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- Octave — The context engine for Growth and GTM engineering teams
- Drafter — automating go to manufacturing
- C-Infinity — Pioneering AI for mechanical design and manufacturing. Our product, AutoAssembler, provides breakthrough assembly intelligence for complex physical systems.
Builders VC is an early-stage venture capital firm focused on investing where technology meets new business models to modernize antiquated industries including healthcare, agriculture, industrials and real-estate.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Mexico
Investor stats
- Total investments: 113
- Round size: Seed $1.8M–$11M; Series A $6M–$21M; Series B $8M–$40M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely still investing — raised $250M in 2022
Portfolio highlights
- Askari Defense — Intelligent Kinetic Defense For the Age of Robotic Warfare
- Astromech — Astromech develops artificial intelligence applications for biotechnology research and development. The company focuses on creating AI platforms that support genetic engineering and synthetic biology initiatives. Its work combines operational expertise in biotechnology ventures with scientific knowledge in genetics, enabling the development ofAI-driven tools for research environments. It operates in a confidential manner, concentrating on technology development without publicly disclosing specific products or applications. Leadership integrates experience in managing complex research projects with advanced scientific insight to guide the company's growth and AI platform development. The company maintains a corporate structure that supports institutional investment while continuing its focus on AI and biotechnology innovation.
- Ichor Microbial Solutions — Ichor Microbial Solutions is a company that offers agricultural services.
Purveyors of warm vibes and cold cash since 2015.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Pre-Seed
- Geography: United States, Canada
Investor stats
- Total investments: 64
- Round size: Seed $750k–$9M; Pre-Seed $125k–$3.2M
- Lead/follow: 0% lead, 100% follow
- Last fund: May invest from a new fund soon — raised $650k in 2019
Portfolio highlights
- Kaaj AI — Unlock faster, profitable small business lending with Agentic AI
- Ergo — Ergo turns conversations into automatic follow-ups, CRM updates, coaching, and forecasting. Reps spend less time on admin work, deals stop slipping.
- Falconer — The self-driving knowledge base. Replace Confluence, Google Docs, and useless meetings.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Yaletown Partners specializes in investing in software, data, and device technologies. It invests in technology companies that improve industry and enterprise productivity and sustainability, to help accelerate their growth, shorten exit timeframes, and accomplish strong exit premiums.With offices in Vancouver, Calgary, Montréal, and a growingpresence in Toronto, Yaletown is led by a national team that contributes almost 100 years of technology-industry experience and a network of extensive industry relationships.
Show more...Investment focus
- Industry: Software, Enterprise Software, Information Technology
- Stage:Series A, Series B, Seed
- Geography: Canada, United States, Belgium
Investor stats
- Total investments: 94
- Round size: Seed $603k–$5.2M; Series A $3.1M–$16M; Series B $2.1M–$60M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely actively investing — fresh fund, raised $100M in 2025
Portfolio highlights
- GHGSat — GHGSat’s mission is to become the global reference for remote sensing of greenhouse gas (GHG), air quality gas, and other trace gas emissions from any source in the world.In June 2016, GHGSat launched the world’s first high-resolution satellite capable of measuring greenhouse gas (CO2 & CH4) emissions from any industrial facility in theworld. GHGSat is using this unique satellite and its patented technology to provide greenhouse gas emissions monitoring data and services globally,with better accuracy and at at a fraction of the cost of comparable alternatives. Owners of industrial facilities are now able to monitor all of their facilities, local or remote, anywhere in the world, with a common technology, in near-real-time. Significantly improved emissions information is enabling industries to better measure, control, and ultimately reduce emissions of GHGs.Building on lessons learned from its demonstration satellite, GHGSat launched its second satellite in Sept 2020 and a third is scheduled for Q1'21. Three more satellites are under construction for launch in early 2022. GHGSat also uses the same instrument technology from its satellites on aircraft, to provide complementary resolution and performance for customers in shale plays. GHGSat’s technology can also be used to monitor air quality gases, as well as other trace gases, in the atmosphere. Business cases are being developed for key markets, such as measuring SOx from ships.
- Oloid — Frictionless and secure passwordless authentication for frontline workers enabling modern cybersecurity and identity and access management for deskless workers and shared devices.
- Nanoprecise Sci Corp — Predictive Maintenance, Automated Ai Based Predictive Maintenance, Machine Doctor, Wireless Industrial Iot Sensors, Artificial Intelligence in Maintenance, Scaling Iot Solutions
Hazelview Ventures provide entrepreneurs with a unique opportunity to refine, scale, and showcase product and service capabilities.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Big Data
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada, Slovakia (Slovak Republic)
Investor stats
- Total investments: 7
- Round size: Seed $2M–$12M
- Lead/follow: 57% lead, 43% follow
Portfolio highlights
- Xaba — Xaba develops intelligent automation solutions, materials and processes to enable a world of sustainable manufacturing.
- Lamarr.AI — Saving Energy Through Automated Building Exterior Inspection AI-powered envelope diagnostics to accelerate the transition to Net Zero buildings. Contact Us About Lamarr.AI Defining pathways for future cities by developing technology innovations Lamarr.AI entered the market in 2023 as the product
- SensorSuite — A Complete Suite Of Monitoring And Control Solutions For Your Boilers & Electrically Heated Buildings
Charles River provides products and services to help expedite the discovery, early-stage development and safe manufacture of novel drugs and therapeutics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Life Science
- Stage:Series A, Series B
- Geography: United States, Canada, France
Investor stats
- Total investments: 14
- Round size: Series A $20M–$31M; Series B $12M–$103M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- Ability biologics — Ability develops innovative, targeted, immune modulating biotherapeutics to address unmet medical needs in patients with cancer and autoimmune diseases.
- Vernal Biosciences — Vernal Biosciences is an mRNA manufacturing company that provides high purity mRNA, from concept to clinical trials, on a transactional basis.
Enabling passionate, committed SaaS entrepreneurs to accelerate growth.
Show more...Investment focus
- Industry: Software, SaaS, Enterprise Software
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 20
- Round size: Series A $7.5M–$21M; Series B $17M–$21M; Venture - Series Unknown $7M–$12M
- Lead/follow: 80% lead, 20% follow
- Last fund: Likely still investing — raised $106M in 2024
Portfolio highlights
- ACTO — ACTO is an omnichannel education platform for life sciences companies. ACTO is an AI-powered SaaS platform built for life sciences that uses mobile experiences and agency partnerships to give learners all the tools they need in one intuitive cross-platform app, and give leaders powerful admin tools with engagement data in one command center.
- AppWork — We are on a mission to modernize multifamily maintenance by giving you the data you need to make informed business decisions.
- Cecilian Partners — Best-in-Class Proptech Solutions: Real estate management, mapping, and development software to support property developers, home builders & realtors.
LVL1 Group is a private investment management firm, operating across different asset classes and geographies. We were founded with entrepreneurial spirit at our core, with a natural passion for venture investing, working closely with founders to forge meaningful strategic relationships and helping them to succeed. We are not bound by mandates andinvestment periods, which allows us to be flexible and opportunistic. We look for companies that aim to make a strong global impact, particularly in Online Travel, Gaming, eSports, Content and Community Platforms.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A, Convertible Note
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $577k–$10M; Series A $2M–$39M; Convertible Note $500k–$46M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- GRACIA.AI — Volumetric video production powered by 4D Gaussian Splatting (4DGS). From multi-camera capture to delivery in any engine, browser, or headset.
- Native Commerce — Grow your business with Jiffy SaaS platform which includes app/website, picking, delivery, supply chain & replenishment services
- Native Commerce — A unified e-commerce platform combining CMS, OMS, WMS, Delivery & Logistics to help modern retailers operate, scale & deliver great e-commerce experiences.
Groupe Roski is a private investment company that has been involved in venture capital since 2013 with companies that improve the quality of life and the environment for individuals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 14
- Round size: Seed $1.5M–$3.9M; Series A $14M–$20M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Spiderwort — Spiderwort is an innovator in all-natural, plant-based biomaterials that have the potential to repair spinal cord injuries and promote healing.
- Groupe Evex — Groupe Evex deals with the commercial real estate projects.
- Marmax — Marmax deals with residential and commercial construction, renovation and roofing.
The Ontario Centres of Excellence invests in projects and people to accelerate industry R&D to impact the Ontario economy through the commercialization of leading edge research.OCE invests in- Industry-Academic collaborative research- Commercialization of academic research through licensing and spin off companies- Early stage seedfinancing of start-ups- Skills development for high quality personnelThe Ontario Centres of Excellence is a not-for-profit corporation founded in 1987. Core funding is provided by the Ontario Ministry of Research and Innovation
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 150
- Lead/follow: no public data
Portfolio highlights
- Uride — Welcome to Uride - your reliable and affordable ridesharing service with a community-focus. Enjoy the ease of quick pickups, lower fares, and a user-friendly app designed to make your travels smoother. Start riding today!
- FluidAI Medical — Real-Time Monitoring for Anastomotic Leaks with Origin, by FluidAI. Early data shows FluidAI's Origin can detect leaks an average of 1.6 days earlier.
- Novel Biotechnology — Novel Biotechnology is building high-throughput bacterial platforms for the biotech industry, with a focus on plasmid DNA manufacturing.
Since 1980, WTI has helped more than 1,300 companies across every innovation sector finance their growth while minimizing dilution.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Canada, Nigeria
Investor stats
- Total investments: 319
- Round size: Seed $1M–$10M; Series A $3M–$21M; Series B $5M–$100M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $375M in 2013
Portfolio highlights
- Meta — At Meta, they work on landmark AI challenges that have the power to transform how scientific knowledge is experienced and consumed. Meta provides innovators throughout the scientific ecosystem with powerful views of the current and future trajectories of science and technology with the goal of making all scientific knowledge computable. Meta’smission is to unlock all of the world’s scientific and technical insights using artificial intelligence.
- RightsFlow — RightsFlow is a leading technology-enabled provider of mechanical licensing and royalty accounting, reporting, and payment services for online music companies, record companies, distributors, artists, and songwriters. The RightsFlow technology powers rapid song identification and provides an unprecedented level of transparency for both licenseesand licensors. RightsFlow specializes in obtaining bulk physical, DPD, and ringtone licenses including streaming, tethered, and limited download rights. Our proprietary licensing technology and 30+ million song database allow us to license content, render accounting, and pay royalties on behalf of clients quickly and accurately, ensuring that rights-holders are paid for the use of their work. RightsFlow was acquired by Google in 2011 and is now part of the team at YouTube helping to simplify music licensing, content identification, accounting and payments for songwriters and publishers worldwide.
- Prosper Medical — Prosper Medical is a telemedicine platform that connects members with physicians for personalized healthcare services.
Pre-seed investment fund focused on the PNW, Western Canada, and beyond.
Show more...Investment focus
- Industry: Financial Services, Credit, FinTech
- Stage:Seed, Venture - Series Unknown
- Geography: United States
Investor stats
- Total investments: 9
- Round size: Seed $1.2M–$9M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Gone — Gone is a goods redistribution platform that offers free pickup of gently used household products.
- Scispot — Connect your research, inventory, & sample data. Automate your workflows with a no-code toolkit. Track & manage your projects. Collaborate & document with your team & partners. All in one spot. Go beyond old-school ELN and LIMS systems.
- Confido Legal — Confido Legal provides a credit/debit card and ACH payment processing platform specifically designed for law firms and legal technology companies. The platform offers features such as automated payment plans, payment pages for firm websites, and integration with financial management tools like QuickBooks Online. Confido Legal aims to enhancefinancial flexibility for law firms, ensuring they never have to turn away clients due to payment issues.
Accelerate Fund supports the growth of early-stage Alberta technology companies with a multi million dollar fund that combines co-investment from angel investors.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 59
- Round size: Seed $1M–$6.6M; Series A $951k–$12M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — raised $15M in 2020
Portfolio highlights
- Dryrun — From lightening fast data imports and automated forecasts, through to unmatched control to model out scenarios, Dryrun is the choice for CFOs managing cash flow for multi-million dollar businesses. Dryrun integrates with Sage Intacct, QuickBooks Online, Xero and Pipedrive.
- Fairly Staffing — On demand shift filling platform for dental offices and dental professionals.
- Chroma Technologies — Chroma Technologies provides financial technology and property solutions to enhance the rental experiences.
Life Science VC funding in Canada at a glance
Stats across 301 deals from 363 investors.
Access all 363 VC funds in Canada Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 363 VC funds investing in Canada Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!